
The JC/BK Quantitative PCR test is used to detect and quantify the amount of viral DNA (viral load) of JC and BK viruses. These two viruses belong to the polyomavirus family. Both viruses are commonly acquired in childhood and remain dormant in the body. BK virus in the kidneys and JC virus in various tissues, without causing illness in healthy individuals.
However, in people with weakened immunity, such as kidney or bone marrow transplant recipients, or those with conditions like HIV/AIDS or diabetes, these viruses can reactivate and cause serious complications.
- BK virus reactivation may lead to polyomavirus-associated nephropathy (PVAN), ureteral problems, or hemorrhagic cystitis.
- JC virus reactivation can affect the brain, causing progressive multifocal leukoencephalopathy (PML), a severe neurological disorder.
Since there are no specific antiviral drugs for these infections, this test plays a key role in monitoring viral load and guiding timely treatment decisions. Regular monitoring helps doctors adjust immunosuppressive therapy to control viral spread, protect kidney function, and prevent rejection reactions after transplantation.
Doctors may recommend the JC/BK Quantitative PCR test when there are unexplained changes in kidney function, neurological symptoms, or when a patient is at risk of viral reactivation due to a weakened immune system. It is commonly advised for transplant recipients or those on immunosuppressive therapy to monitor for early signs of infection. The test helps track viral levels in the blood, guiding doctors in adjusting treatment or medications to prevent complications and ensure better recovery outcomes.
For this test, a MedGenome Micra TRF form must be filled out. It is important to provide a detailed clinical history and current drug regimen along with the form for accurate interpretation and reporting.
Lab test results may vary across different laboratories. Abnormal test results require an expert interpretation. Therefore, never try to self-medicate at home based solely on these results, and always consult a doctor for a proper understanding of the test results.
The JC/BK Quantitative PCR test measures the presence and amount of JC virus (JCV) and BK virus (BKV) DNA in the blood using Real-Time Polymerase Chain Reaction (RT-PCR) technology. This method amplifies even very small amounts of viral genetic material, making it highly sensitive and accurate for early detection. High levels of JC viral DNA may indicate an active infection and are associated with an increased risk of Progressive Multifocal Leukoencephalopathy (PML), a serious neurological condition. Similarly, elevated BK viral DNA levels suggest active infection, which can lead to complications such as BK virus-associated nephropathy (BKVAN) or urinary tract issues, particularly in transplant recipients. Low or undetectable levels of either virus generally indicate that the infection is inactive or well-controlled. By quantifying viral load, this test enables regular monitoring, helps detect early reactivation, guides treatment decisions, allows adjustment of immunosuppressive therapy, and aids in preventing serious complications.
The JC/BK Quantitative PCR test is done:
- To detect active BK or JC virus infections in at-risk individuals
- To monitor viral activity in kidney or bone marrow transplant recipients
- To assess the causes of declining kidney function after transplantation
- To detect complications like BK virus nephropathy, hemorrhagic cystitis, or JC virus-associated PML
- To guide treatment decisions and adjust immunosuppressive therapy
- For routine post-transplant or immunocompromised patient monitoring
- Medgenome MIcra TRF to be filled.
- Clinical history and drug regimen should be provided.





















